SpyGlass Pharma, Inc. Common Stock
NASDAQ:SGPBiotechnology
+$0.45 today
- Market cap
- $993.14M
- Beta
- -0.34
- P/E (TTM)
- -14.1
- EPS (TTM)
- -$1.32
Volume 0.10M
Average 0.09M
SGP Total Liabilities
Everything the company owes to creditors and other parties.
SpyGlass Pharma, Inc. Common StockNASDAQ: SGP
Total Liabilities · Q1 FY2026 · quarter ended Mar 2026
Total liabilities of $8.27M in Q1 FY2026
Q1 FY2026 total liabilities was $8.27M.
Context
- Total liabilities amounted to 3.2% of total assets at the end of Q1 FY2026.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Liabilities history
USD · from the balance sheet
- Latest · FY2025
- 214.7M USD
- Year-over-year change
- —
| Period | Period end | Total Liabilities | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 214.7M | — |
Total Liabilities vs competitors
How SGP compares with its peers on the latest reported figures
- Peers report in different currencies, so total liabilities is compared through growth and share of total assets rather than absolute size.
- Total liabilities amounts to 3.2% of total assets for SGP, versus a peer median of 21.9%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Sep 2026 | $9.63B USD | +2.2% | -0.0% | 30.7% | |
| Jun 2026 | $7.42B USD | +1.2% | +22.9% | 53.5% | |
| Jun 2026 | $238.04M USD | +7.3% | -24.2% | 25.9% | |
| Mar 2026 | $150.96M USD | +7.8% | +10.5% | 20.6% | |
| Apr 2026 | $98.75M USD | -8.0% | +12.4% | 21.9% | |
| Mar 2026 | $57.75M USD | -10.0% | -11.7% | 20.0% | |
| Mar 2026 | $55.8M USD | +7.2% | -1.0% | 50.9% | |
| Mar 2026 | CHF 47.2M CHF | +13.6% | -33.4% | 19.4% | |
| Mar 2026 | $36.7M USD | +8.8% | -15.7% | 12.1% | |
SGPSpyGlass Pharma, Inc. Common Stock | Mar 2026 | $8.27M USD | — | — | 3.2% |
| Peer median (excluding SGP) | — | +7.2% | -1.0% | 21.9% | |
Competitors are the stored peer set for SGP. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
SpyGlass Pharma, Inc. Common Stock
NASDAQ:SGP
Intrinsic Alpha fair value
Locked
Current Price
$29.68
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.